We are live on
!
Find out more
VCAM
Valentine Capital Asset Management Portfolio holdings
AUM
$89.6M
1-Year Est. Return
0.84%
This Fund
S&P 500
This Quarter
Est. Return
+6.71%
1 Year Est. Return
-0.84%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$342M
AUM Growth
-$68.9M
(-17%)
Cap. Flow
-$82.1M
Cap. Flow
% of AUM
-23.97%
Top 10 Holdings %
Top 10 Hldgs %
26.17%
Holding
108
New
10
Increased
3
Reduced
82
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ProShares UltraPro Short S&P 500
SPXU
|
+$8.51M |
| 2 |
Precigen
PGEN
|
+$4.1M |
| 3 |
JMBA
Jamba, Inc.
JMBA
|
+$3.25M |
| 4 |
SDRL
Seadrill Limited Common Stock
SDRL
|
+$3.08M |
| 5 |
Gilead Sciences
GILD
|
+$3.08M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$9.43M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$7.19M |
| 3 |
State Street SPDR S&P Retail ETF
XRT
|
+$6.95M |
| 4 |
Perrigo
PRGO
|
+$6.74M |
| 5 |
Nu Skin
NUS
|
+$6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13% |
| 2 | Healthcare | 12.98% |
| 3 | Technology | 7.52% |
| 4 | Energy | 5.85% |
| 5 | Real Estate | 4.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
ProShares UltraPro Short S&P 500
SPXU
$406M
| $14.6M | 4.27% |
1,015
+575
| +131% | +$8.51M |
|
|
TARO
2
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $10.7M | 3.13% |
76,023
-18,185
| -19% | -$2.8M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $9.85M | 2.87% |
33,079
-2,471
| -7% | -$704K |
|
4
ProShares Ultra NASDAQ Biotechnology
BIB
$81.2M
| $8.65M | 2.53% |
109,196
+4,630
| +4% | +$343K |
|
5
Chevron
CVX
$392B
| $8.34M | 2.43% |
79,427
-38,509
| -33% | -$4.11M |
|
6
iShares China Large-Cap ETF
FXI
$4.37B
| $8.07M | 2.36% |
181,805
-41,420
| -19% | -$1.76M |
|
7
Direxion Daily Financial Bull 3x ETF
FAS
$2.44B
| $7.67M | 2.24% |
250,848
+24,160
| +11% | +$730K |
|
8
Omega Healthcare
OHI
$15.1B
| $7.27M | 2.12% |
179,176
-41,350
| -19% | -$1.71M |
|
9
Ambarella
AMBA
$3.77B
| $7.25M | 2.12% |
95,694
-22,400
| -19% | -$1.36M |
|
10
Jazz Pharmaceuticals
JAZZ
$15.9B
| $7.19M | 2.1% |
41,626
-15,201
| -27% | -$2.61M |
|
|
SWIR
11
DELISTED
Sierra Wireless
SWIR
| $7.05M | 2.06% |
213,115
-49,780
| -19% | -$1.87M |
|
|
IFN
12
Aberdeen India Fund
IFN
$499M
| $6.7M | 1.96% |
236,843
-20,431
| -8% | -$585K |
|
13
B&G Foods
BGS
$287M
| $6.18M | 1.81% |
210,150
-43,450
| -17% | -$1.28M |
|
14
State Street SPDR S&P Biotech ETF
XBI
$9.95B
| $5.85M | 1.71% |
77,880
-19,335
| -20% | -$1.35M |
|
|
SVC
15
Service Properties Trust
SVC
$1.04B
| $5.82M | 1.7% |
35,515
-7,826
| -18% | -$1.25M |
|
16
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $5.73M | 1.67% |
48,445
-11,190
| -19% | -$1.27M |
|
17
Direxion Daily MSCI India Bull 2X ETF
INDL
$57.2M
| $5.58M | 1.63% |
73,435
-3,335
| -4% | -$260K |
|
|
SLXP
18
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $5.56M | 1.62% |
32,200
-8,100
| -20% | -$1.19M |
|
19
ProShares Ultra Energy
DIG
$82.8M
| $5.49M | 1.6% |
86,631
-18,404
| -18% | -$1.18M |
|
20
iShares MSCI Hong Kong ETF
EWH
$1.24B
| $5.16M | 1.51% |
235,288
-53,755
| -19% | -$1.15M |
|
|
AKRX
21
DELISTED
Akorn Inc
AKRX
| $5.15M | 1.5% |
108,400
-23,300
| -18% | -$1.06M |
|
22
iShares Core MSCI Emerging Markets ETF
IEMG
$150B
| $5.01M | 1.46% |
124,960
-28,410
| -19% | -$1.36M |
|
23
Lowe's Companies
LOW
$117B
| $4.96M | 1.45% |
66,685
-16,420
| -20% | -$1.18M |
|
|
24
Precigen
PGEN
$2.24B
| $4.95M | 1.44% |
+114,050
| New | +$4.1M |
|
|
FRGI
25
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $4.87M | 1.42% |
79,900
-31,550
| -28% | -$1.97M |
|
Similar funds
TSBJ
TP
SPC
DA
KCA
CCM
ST
HCM
Valentine Capital Asset Management's Q1 2015 Portfolio in Review
As of Q1 2015, Valentine Capital Asset Management held 108 positions worth $342M, down 17% from $411M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Valentine Capital Asset Management withdrew a net $82.1M in Q1 2015, closing 13 positions and reducing 82 holdings. Its most notable exit was iShares Core MSCI EAFE ETF, an estimated $7.19M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Valentine Capital Asset Management opened a new position in Precigen worth $4.95M.
- Valentine Capital Asset Management's largest Q1 2015 buy was Precigen: 114,050 shares worth $4.95M.
- Valentine Capital Asset Management added most to ProShares UltraPro Short S&P 500 in Q1 2015, an estimated $8.51M increase.
- Valentine Capital Asset Management's biggest Q1 2015 reduction was Walt Disney, cutting an estimated $9.43M.
- Valentine Capital Asset Management fully exited iShares Core MSCI EAFE ETF in Q1 2015, selling an estimated $7.19M.
- Valentine Capital Asset Management's ten largest holdings make up 26% of its $342M portfolio in Q1 2015.
- Valentine Capital Asset Management opened 10 new positions and closed 13 in Q1 2015.
- Valentine Capital Asset Management's portfolio value fell 17% quarter-over-quarter to $342M.
Based on Valentine Capital Asset Management's 13F filing for Q1 2015, filed 9 Apr 2015.